ロード中...
Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity
SIMPLE SUMMARY: Multiple myeloma is a bone marrow cancer that represents a severe health threat. The drugs used nowadays in chemotherapy often encounter resistance leading to a dramatic loss of their efficacy, which consequently affects patients’ survival. Previous studies have shown that the protei...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7601861/ https://ncbi.nlm.nih.gov/pubmed/33028016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102864 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|